Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease

[1]  P. Dicorleto,et al.  IFN-gamma inhibits double-stranded RNA-induced E-selectin expression in human endothelial cells. , 1997, Journal of immunology.

[2]  N. Yamashita,et al.  Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behçet's disease. , 1997, International reviews of immunology.

[3]  W. Stremmel,et al.  Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides. , 1996, The American journal of medicine.

[4]  G. Marshall,et al.  Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis , 1996, Neurology.

[5]  R. Mcmurray,et al.  Adhesion molecules in autoimmune disease. , 1996, Seminars in arthritis and rheumatism.

[6]  N. Sayınalp,et al.  Cytokines in Behçet's disease. , 1996, The Journal of rheumatology.

[7]  P. Chapman,et al.  Leukocyte adhesion molecules. , 1995, British medical bulletin.

[8]  E. Alpsoy,et al.  Interferon therapy for Behçet's disease. , 1994, Journal of the American Academy of Dermatology.

[9]  C. Zouboulis,et al.  [Adamantiades-Behçet disease. Therapeutic administration of systemic recombinant interferon-alpha-2a]. , 1993, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[10]  T. V. Gopal,et al.  Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. , 1993, Journal of immunology.

[11]  K. Ayed,et al.  Production of TNF-alpha and IL-1 in active Behçet's disease. , 1990, The Journal of rheumatology.

[12]  H. Yazıcı,et al.  TNF, soluble IL-2R and soluble CD-8 in Behçet's disease. , 1990, The Journal of rheumatology.

[13]  J. Dayer,et al.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[14]  S. Dündar.  Vena Caval Obstruction in Behçet's Disease , 1988, Journal of the Royal Society of Medicine.

[15]  T. Hoshino,et al.  Analysis of interleukin-2 activity in patients with Behçet's disease. Ability of T cells to produce and respond to interleukin-2. , 1986, Arthritis and rheumatism.

[16]  T. Lehner,et al.  An immunogenetic basis for the tissue involvement in Behçet's syndrome. , 1979, Immunology.

[17]  H. Behcet.  UBER REZIDIVERENDE APHTHOSE DURCH EIN VIRUS VERURSACHTE GESCHWURE AM MUND, AM AUGE UND AN DEN GENITALIEN , 1937 .